Cite
MLA Citation
Toshiaki Tanaka et al.. “Potential Survival Benefit of Anti-Apoptosis Protein: Survivin-Derived Peptide Vaccine with and without Interferon Alpha Therapy for Patients with Advanced or Recurrent Urothelial Cancer—Results from Phase I Clinical Trials.” Clinical & developmental immunology, vol. 2013, 2013, p. . http://access.bl.uk/ark:/81055/vdc_100130167440.0x00003b